Related references
Note: Only part of the references are listed.Management of Locally Advanced Pancreatic Cancer Results of an International Survey of Current Practice
Bradley N. Reames et al.
ANNALS OF SURGERY (2021)
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
Therese M. -L. Andersson et al.
BRITISH JOURNAL OF CANCER (2021)
Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2
Citadel J. Cabasag et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Effect of centralization and regionalization of pancreatic surgery on resection rates and survival
A. E. J. Latenstein et al.
BRITISH JOURNAL OF SURGERY (2021)
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Anouk E. J. Latenstein et al.
ACTA ONCOLOGICA (2020)
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
Anouk E. J. Latenstein et al.
EUROPEAN JOURNAL OF CANCER (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Centralization of Pancreatic Surgery Improves Results: Review
R. Ahola et al.
SCANDINAVIAN JOURNAL OF SURGERY (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
The proportion of missing data should not be used to guide decisions on multiple imputation
Paul Madley-Dowd et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement
Douglas K. Owens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold et al.
LANCET ONCOLOGY (2019)
Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015
Tracey S. E. Genus et al.
BRITISH JOURNAL OF CANCER (2019)
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Akram Pourshams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Nicolas Williet et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors A Population-based Study
Siddhartha Yadav et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
Lei Huang et al.
BMC MEDICINE (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Impact of centralization of pancreatic cancer surgery on resection rates and survival
G. A. Gooiker et al.
BRITISH JOURNAL OF SURGERY (2014)
Early detection and prevention of pancreatic cancer: Is it really possible today?
Marco Del Chiaro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A comprehensive assessment of the impact of errors in the cancer registration process on 1-and 5-year relative survival estimates
M. J. Rutherford et al.
BRITISH JOURNAL OF CANCER (2013)
Young Patients Undergoing Resection of Pancreatic Cancer Fare Better than their Older Counterparts
Jin He et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Evidence for Treatment and Survival Disparities by Age in Pancreatic Adenocarcinoma A Population-Based Analysis
Sunil Amin et al.
PANCREAS (2013)
Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
Cynthia Ro et al.
CHINESE JOURNAL OF CANCER (2013)
Identifying people at a high risk of developing pancreatic cancer
Alison P. Klein
NATURE REVIEWS CANCER (2013)
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Faruk Tas et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Share Paper
